The 49th Union World Conference on Lung Health, held from 24-27 October in The Hague brought together an unprecedented number of stakeholders from the TB community and beyond. The World Health Organization (WHO) organized several meetings and consultations on the side-lines of the conference.

24 October 2018, New York - WHO and partners released a series of documents today to improve drug susceptibility testing for TB in laboratories worldwide.

First-ever targeted roadmap outlines steps to scale-up public-private health sector engagement to end TB.

The World Health Organization (WHO) and FIND released a technical guide on sequencing, The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide.

The World Health Organization and the Global Fund today signed a Global Strategic Framework as a foundation for closer collaboration, based on respective mandates and strengths, and with commitment toward achieving the Sustainable Development Goals. It was signed by Dr. Tedros Adhanom Ghebreyesus, Director-General of WHO, and Peter Sands, Executive Director of the Global Fund.

The World Health Organization (WHO)'s Global TB Program released a newsletter featuring highlights from the UN High-Level Meeting on TB, held on 26 September 2018.

The World Health Organization (WHO) in collaboration with the Stop TB Partnership’s Global Drug Facility, the Global Fund to Fight AIDS, Tuberculosis and Malaria and the United States Agency for International Development have developed a set of frequently asked questions (and answers) in response to inquiries on upcoming WHO policy recommendations.

A new action plan outlines measures to prevent and treat TB in children and adolescents.

WHO’s 2018 Global TB Report calls for an unprecedented mobilization of national and international commitments; First-ever United Nations High-Level Meeting on TB provides historic opportunity.

Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.